<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Paronychia</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Paronychia</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Paronychia</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Beth G Goldstein, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Adam O Goldstein, MD, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Antonella Tosti, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert P Dellavalle, MD, PhD, MSPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Moise L Levy, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Rosamaria Corona, MD, DSc</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 25, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Paronychia is an inflammation involving the lateral and proximal nail folds. It may be acute (lasting for less than six weeks) or chronic (lasting for six weeks or longer) [<a href="#rid1">1</a>]. Predisposing factors include overzealous manicuring, nail biting, picking at a hangnail, thumbsucking, ingrown nail, diabetes mellitus, and occupations in which the hands are frequently immersed in water [<a href="#rid2">2</a>]. Paronychia has also been reported as an adverse effect of several drugs, including antiretroviral agents [<a href="#rid3">3,4</a>], systemic retinoids, epidermal growth factor receptor (EGFR) inhibitors, and cytotoxic chemotherapy agents [<a href="#rid5">5,6</a>].</p><p>This topic will discuss the pathogenesis, clinical manifestations, and management of acute and chronic paronychia. Ingrown toenails and other nail disorders are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/131356.html" rel="external">"Ingrown nails"</a> and  <a class="medical medical_review" href="/z/d/html/13682.html" rel="external">"Overview of nail disorders"</a> and  <a class="medical medical_review" href="/z/d/html/96391.html" rel="external">"Nail psoriasis"</a> and  <a class="medical medical_review" href="/z/d/html/16202.html" rel="external">"Principles and overview of nail surgery"</a> and  <a class="medical medical_review" href="/z/d/html/1735.html" rel="external">"Nail avulsion and chemical matricectomy"</a> and  <a class="medical medical_review" href="/z/d/html/13709.html" rel="external">"Nail biopsy: Indications and techniques"</a> and  <a class="medical medical_review" href="/z/d/html/100032.html" rel="external">"Dermoscopy of nail pigmentations"</a> and  <a class="medical medical_review" href="/z/d/html/100033.html" rel="external">"Dermoscopy of nonpigmented nail lesions"</a>.)</p><p class="headingAnchor" id="H3673656800"><span class="h1">ACUTE PARONYCHIA</span></p><p class="headingAnchor" id="H3021719340"><span class="h2">Definition</span><span class="headingEndMark"> — </span>Acute paronychia is an acute inflammatory process, with or without abscess formation, that involves the proximal and lateral nail folds and that has been present for less than six weeks [<a href="#rid1">1,7</a>].</p><p class="headingAnchor" id="H1543631374"><span class="h2">Pathogenesis</span></p><p class="headingAnchor" id="H620731057"><span class="h3">Infectious agents</span><span class="headingEndMark"> — </span>Acute paronychia is most commonly caused by the inoculation of pathogens present in the skin flora (eg, <em>Staphylococcus aureus</em>, <em>Streptococcus pyogenes</em>) into the periungual tissues by minor mechanical or chemical traumas that disrupt the nail fold barrier [<a href="#rid7">7</a>]. Other organisms that may be occasionally involved, especially in acute episodes occurring in patients with chronic paronychia, include <em>Pseudomonas aeruginosa</em> and other Gram-negative bacteria.</p><p>In digits exposed to oral flora, acute paronychia may be caused by either skin or oral flora. In this setting, organisms include both aerobic bacteria (such as streptococci, <em>S. aureus</em>, and <em>Eikenella corrodens</em>) and anaerobic bacteria (eg, <em>Fusobacterium</em>, <em>Peptostreptococcus</em>, <em>Prevotella</em>, <em>Porphyromonas</em> spp) [<a href="#rid8">8,9</a>].</p><p class="headingAnchor" id="H808210756"><span class="h3">Drugs</span><span class="headingEndMark"> — </span>Acute paronychia may be an adverse effect of several drugs, including epidermal growth factor receptor (EGFR) inhibitors (eg, <a class="drug drug_general" data-topicid="9209" href="/z/d/drug information/9209.html" rel="external">cetuximab</a>, <a class="drug drug_general" data-topicid="8736" href="/z/d/drug information/8736.html" rel="external">erlotinib</a>, <a class="drug drug_general" data-topicid="10336" href="/z/d/drug information/10336.html" rel="external">panitumumab</a>, <a class="drug drug_general" data-topicid="10093" href="/z/d/drug information/10093.html" rel="external">lapatinib</a>), cytotoxic chemotherapy agents (eg, taxanes, <a class="drug drug_general" data-topicid="8839" href="/z/d/drug information/8839.html" rel="external">capecitabine</a>, <a class="drug drug_general" data-topicid="9630" href="/z/d/drug information/9630.html" rel="external">methotrexate</a>, <a class="drug drug_general" data-topicid="9391" href="/z/d/drug information/9391.html" rel="external">doxorubicin</a>) [<a href="#rid5">5,6</a>], systemic retinoids [<a href="#rid10">10-12</a>], and antiretroviral agents [<a href="#rid4">4,13-15</a>]. In patients treated with EGFR inhibitors, paronychia is thought to result from EGFR-induced changes in differentiation and migration of keratinocytes and decrease in keratinocyte proliferation and survival [<a href="#rid5">5</a>]. Although the periungual lesions are initially sterile, bacterial superinfection is common and may lead to abscess formation. </p><p class="headingAnchor" id="H1137604929"><span class="h2">Predisposing factors</span><span class="headingEndMark"> — </span>Common favoring factors for acute paronychia of the fingernails include manicuring, nail biting, thumbsucking, and picking at a hangnail. Acute paronychia of the toes occurs in most cases in association with ingrown toenails [<a href="#rid16">16</a>]. (See  <a class="medical medical_review" href="/z/d/html/131356.html" rel="external">"Ingrown nails"</a>.) </p><p class="headingAnchor" id="H2031835014"><span class="h2">Clinical presentation</span><span class="headingEndMark"> — </span>Acute paronychia is characterized by the rapid onset of painful erythema and swelling of the proximal and lateral nail folds, usually in two to five days following a minor local trauma. A superficial abscess is frequently present  (<a class="graphic graphic_picture graphicRef70107 graphicRef112832 graphicRef60833" href="/z/d/graphic/70107.html" rel="external">picture 1A-C</a>). The infection may occasionally extend along the proximal nail fold to the opposite side of the nail, resulting in the so-called "runaround infection." </p><p>Paronychia usually involves one finger. Multiple nails can be involved in drug-induced paronychia. </p><p>Toenail paronychia is most often associated with ingrown toenail or retronychia (ingrowth of the nail plate into the proximal nail fold) [<a href="#rid16">16</a>]. It may also occur in patients with congenital malalignment of the great toenails [<a href="#rid17">17</a>]. (See  <a class="medical medical_review" href="/z/d/html/131356.html" rel="external">"Ingrown nails"</a> and  <a class="medical medical_review" href="/z/d/html/13682.html" rel="external">"Overview of nail disorders", section on 'Retronychia'</a>.) </p><p class="headingAnchor" id="H3055334874"><span class="h2">Complications</span><span class="headingEndMark"> — </span>In rare cases, the infection may spread to the underlying nail bed or to the pulp space (felon)  (<a class="graphic graphic_figure graphicRef80567" href="/z/d/graphic/80567.html" rel="external">figure 1</a>) [<a href="#rid18">18</a>]. Felon requires prompt surgical treatment with incision and drainage to prevent the development of osteomyelitis, permanent nail deformities, and ischemic necrosis of the fingertip [<a href="#rid19">19</a>]. (See  <a class="medical medical_review" href="/z/d/html/15117.html" rel="external">"Overview of hand infections", section on 'Superficial hand infections'</a>.)</p><p>Late complications of acute paronychia include dystrophic changes of the nail plate, such as transverse nail plate grooves (Beau lines)  (<a class="graphic graphic_picture graphicRef85706" href="/z/d/graphic/85706.html" rel="external">picture 2</a>), onychomadesis (detachment of the nail plate)  (<a class="graphic graphic_picture graphicRef85705" href="/z/d/graphic/85705.html" rel="external">picture 3</a>), and permanent nail dystrophy.</p><p class="headingAnchor" id="H2"><span class="h2">Diagnosis</span><span class="headingEndMark"> — </span>The diagnosis of acute paronychia is usually straightforward, based upon a history of local minor trauma and the clinical finding of swollen, tender proximal or lateral nail folds, often associated with a purulent fluid collection  (<a class="graphic graphic_picture graphicRef70107 graphicRef80162 graphicRef60833" href="/z/d/graphic/70107.html" rel="external">picture 1A, 1C-D</a>). Usually, these findings have been present for less than six weeks. A digital pressure test has been suggested as a simple method to identify the presence and extent of a paronychial abscess [<a href="#rid20">20</a>]. A blanching appearing on the paronychium after applying a mild pressure to the volar aspect of the tip of the affected finger indicates the presence of an abscess. </p><p>Laboratory tests are usually not necessary for the diagnosis. However, in patients with severe infection and abscess, a pus culture should be obtained to guide antimicrobial therapy.</p><p class="headingAnchor" id="H337123818"><span class="h2">Differential diagnosis</span><span class="headingEndMark"> — </span>The differential diagnosis of paronychia includes the following:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Felon</strong> – Paronychia must be distinguished from felon, an infection of the digital pulp space  (<a class="graphic graphic_picture graphicRef55298" href="/z/d/graphic/55298.html" rel="external">picture 4</a> and <a class="graphic graphic_figure graphicRef69094" href="/z/d/graphic/69094.html" rel="external">figure 2</a>) characterized by severe pain, swelling, and erythema in the pad of the fingertip that is typically more dramatic than the onset of paronychia. (See  <a class="medical medical_review" href="/z/d/html/15117.html" rel="external">"Overview of hand infections", section on 'Superficial hand infections'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Herpetic whitlow</strong> – Acute onset is associated with vesicles, vesicopustules, severe edema, erythema, or pain  (<a class="graphic graphic_picture graphicRef75510" href="/z/d/graphic/75510.html" rel="external">picture 5</a>). The patient should be asked about exposure to herpes simplex virus (HSV). Tzanck staining of vesicles will demonstrate multinucleated giant cells. Immunofluorescence staining and viral culture can also be used to confirm HSV infection. (See  <a class="medical medical_review" href="/z/d/html/8334.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of herpes simplex virus type 1 infection", section on 'Herpetic whitlow'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acrodermatitis continua of Hallopeau</strong> – Acrodermatitis continua of Hallopeau is a rare variant of pustular psoriasis characterized by a chronic, relapsing, inflammatory eruption with sterile pustules that primarily involves the distal fingers or toes, nail folds, and nail beds  (<a class="graphic graphic_picture graphicRef69799" href="/z/d/graphic/69799.html" rel="external">picture 6</a>) [<a href="#rid21">21</a>]. The initial presentation of acrodermatitis continua of Hallopeau may mimic acute paronychia; however, unlike acute paronychia, pustules are sterile. Nail destruction is a prominent feature of long-standing disease  (<a class="graphic graphic_picture graphicRef94791" href="/z/d/graphic/94791.html" rel="external">picture 7</a>). (See  <a class="medical medical_review" href="/z/d/html/89271.html" rel="external">"Pustular psoriasis: Pathogenesis, clinical manifestations, and diagnosis", section on 'Acrodermatitis continua of Hallopeau'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Proximal onychomycosis</strong> – Proximal subungual onychomycosis due to molds is typically associated with erythema, swelling of the proximal nail fold, and occasionally with purulent discharge  (<a class="graphic graphic_picture graphicRef113381" href="/z/d/graphic/113381.html" rel="external">picture 8</a>) [<a href="#rid22">22</a>]. (See  <a class="medical medical_review" href="/z/d/html/4034.html" rel="external">"Onychomycosis: Epidemiology, clinical features, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Green nail syndrome</strong> – Infection of the nail plate from <em>P. aeruginosa</em>, also called green nail syndrome or chloronychia, causes a nail plate blue-green discoloration  (<a class="graphic graphic_picture graphicRef85584 graphicRef74676" href="/z/d/graphic/85584.html" rel="external">picture 9A-B</a>). Prolonged exposure to water is a predisposing factor. In some cases, this condition may occur simultaneously with chronic paronychia [<a href="#rid23">23</a>]. (See  <a class="medical medical_review" href="/z/d/html/7643.html" rel="external">"Pseudomonas aeruginosa skin and soft tissue infections", section on 'Green nail syndrome'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Retronychia</strong> – A rare entity of multiple generations of nail plate growth backwards beneath the proximal nail fold  (<a class="graphic graphic_picture graphicRef107802" href="/z/d/graphic/107802.html" rel="external">picture 10</a>) [<a href="#rid24">24</a>]. (See  <a class="medical medical_review" href="/z/d/html/13682.html" rel="external">"Overview of nail disorders", section on 'Retronychia'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pemphigus vulgaris</strong> – Acute paronychia is a relatively common clinical feature of pemphigus vulgaris [<a href="#rid25">25-27</a>]. (See  <a class="medical medical_review" href="/z/d/html/83684.html" rel="external">"Pathogenesis, clinical manifestations, and diagnosis of pemphigus"</a>.)</p><p></p><p class="headingAnchor" id="H3"><span class="h2">Treatment</span><span class="headingEndMark"> — </span>The treatment of acute paronychia includes local skin-care measures, topical or oral antibiotics, and surgical modalities, depending upon the severity of inflammation and presence or absence of abscess or associated ingrown toenail. There are no high-quality studies evaluating the use of oral versus topical antibiotics for uncomplicated paronychia or the use of oral antibiotics in addition to surgical incision and drainage for acute paronychia with abscess [<a href="#rid28">28</a>]. The approach to treatment is thus based upon clinical experience and limited evidence from observational studies  (<a class="graphic graphic_algorithm graphicRef132191" href="/z/d/graphic/132191.html" rel="external">algorithm 1</a>).</p><p class="headingAnchor" id="H3352425043"><span class="h3">Paronychia without abscess</span><span class="headingEndMark"> — </span>In patients with inflammation without abscess formation, treatment with topical antibiotics and warm water or antiseptic soaks (eg, <a class="drug drug_general" data-topicid="9244" href="/z/d/drug information/9244.html" rel="external">chlorhexidine</a>, povidone-iodine) multiple times per day is usually effective  (<a class="graphic graphic_algorithm graphicRef132191" href="/z/d/graphic/132191.html" rel="external">algorithm 1</a>) [<a href="#rid29">29</a>]. We typically instruct the patient to apply an antistaphylococcal antibiotic (eg, triple antibiotic ointment or <a class="drug drug_general" data-topicid="9668" href="/z/d/drug information/9668.html" rel="external">mupirocin</a>) after each warm soak. Warm soaks should last 10 to 15 minutes. </p><p>A single nonrandomized study compared the efficacy of a combination of topical <a class="drug drug_general" data-topicid="8648" href="/z/d/drug information/8648.html" rel="external">fusidic acid</a> plus <a class="drug drug_general" data-topicid="9139" href="/z/d/drug information/9139.html" rel="external">betamethasone</a> valerate with topical gentamycin in 20 patients with uncomplicated acute paronychia that did not require treatment with oral antibiotics [<a href="#rid29">29</a>]. Both treatments were effective in reducing pain, redness, and swelling.</p><p>Empiric oral antibiotic therapy may be needed in more severe cases that do not respond to topical treatment alone. An antistaphylococcal agent such as <a class="drug drug_general" data-topicid="9349" href="/z/d/drug information/9349.html" rel="external">dicloxacillin</a> (250 mg four times daily) or <a class="drug drug_general" data-topicid="9231" href="/z/d/drug information/9231.html" rel="external">cephalexin</a> (500 mg three to four times daily) is an appropriate first-line therapy. (See  <a class="medical medical_review" href="/z/d/html/110530.html" rel="external">"Acute cellulitis and erysipelas in adults: Treatment", section on 'Without an indication for MRSA coverage'</a>.)</p><p>In patients with risk factors for methicillin-resistant <em>S. aureus</em> (MRSA) colonization  (<a class="graphic graphic_table graphicRef53504" href="/z/d/graphic/53504.html" rel="external">table 1</a>), oral agents that cover local strains of MRSA are a reasonable choice [<a href="#rid30">30</a>]. Options for empiric oral therapy with activity against MRSA include <a class="drug drug_general" data-topicid="9785" href="/z/d/drug information/9785.html" rel="external">trimethoprim-sulfamethoxazole</a> (one to two double-strength tablets twice daily), <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">clindamycin</a> (300 to 450 mg four times per day), or <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a> (100 mg twice daily). (See  <a class="medical medical_review" href="/z/d/html/110530.html" rel="external">"Acute cellulitis and erysipelas in adults: Treatment", section on 'With an indication for MRSA coverage'</a>.)</p><p>For patients with a digit that has been exposed to oral flora (nail biting, finger sucking), antibiotic coverage should include <em>S. aureus, E. corrodens, Haemophilus influenzae</em>, and beta-lactamase-producing oral anaerobic bacteria  (<a class="graphic graphic_table graphicRef80408" href="/z/d/graphic/80408.html" rel="external">table 2</a>). Considerations regarding coverage for MRSA are the same as those discussed above.</p><p class="headingAnchor" id="H894237494"><span class="h3">Paronychia with abscess</span><span class="headingEndMark"> — </span>Acute paronychia with abscess formation is generally treated with incision and drainage  (<a class="graphic graphic_algorithm graphicRef132191" href="/z/d/graphic/132191.html" rel="external">algorithm 1</a>). Several surgical techniques have been described, although there is no consensus among experts on the best procedure or on the need for topical or systemic antibiotic therapy following the abscess drainage [<a href="#rid28">28</a>]. However, given the increasing frequency of MRSA infections, we suggest that a pus culture be obtained for all drained paronychias.</p><p>In a prospective study, 46 patients (26 with paronychia with abscess, 17 with paronychia and felon, and 3 with felon) were treated with incision and drainage alone without oral antibiotics [<a href="#rid31">31</a>]. Forty-five patients were healed without complications at 45 days. The authors concluded that for patients who are not at risk for infectious complications, postoperative antibiotic therapy is not warranted.</p><p>Incision and drainage is often performed by the insertion of a number 11 surgical blade under the affected cuticle margin, after appropriate local anesthesia (digital block or <a class="drug drug_general" data-topicid="8930" href="/z/d/drug information/8930.html" rel="external">ethyl chloride</a> spray) (see  <a class="medical medical_review" href="/z/d/html/262.html" rel="external">"Digital nerve block"</a>). Extension of the incision along the lateral nail fold is indicated if the infection is unilateral. Incisions along both sides of the nail may be necessary for runaround abscess.</p><p>Another method that can be used when the abscess is superficially located is to use a large-gauge needle and run it (bevel down) along the nail fold and into the abscess. In one report, a 23 or 21 gauge needle was used to lift the nail fold off the nail plate, allowing passive oozing of pus [<a href="#rid32">32</a>]. This procedure did not require local anesthesia. </p><p>A partial nail plate removal is usually performed for the treatment of paronychia associated with ingrown toenail. However, a partial or complete nail plate removal may also be needed for patients with abscess extending to the nail bed.</p><p>After incision and drainage, frequent warm soaks will help to maintain the patency of the incision and assist wound drainage. Drainage alone is sufficient for many cases of paronychia with abscess formation [<a href="#rid31">31</a>]. </p><p>However, for more severe cases or in immunosuppressed patients, we administer a course of oral antibiotics following incision and drainage of the abscess. Antibiotic treatment is typically given for five days. When available, culture and susceptibility results should be used to tailor antibiotic therapy. </p><p>The approach to selecting empiric antibiotic therapy is the same as for paronychia without abscess. (See <a class="local">'Paronychia without abscess'</a> above.)</p><p class="headingAnchor" id="H932788677"><span class="h3">Toenail paronychia</span><span class="headingEndMark"> — </span>Acute paronychia of the toenails is usually associated with ingrowing nail or retronychia [<a href="#rid16">16</a>]. Treatment should be addressed to both the acute inflammation and the underlying condition. (See  <a class="medical medical_review" href="/z/d/html/13682.html" rel="external">"Overview of nail disorders", section on 'Retronychia'</a> and  <a class="medical medical_review" href="/z/d/html/131356.html" rel="external">"Ingrown nails"</a>.)</p><p class="headingAnchor" id="H3820903935"><span class="h3">Drug-induced paronychia</span><span class="headingEndMark"> — </span>In most cases, drug-induced paronychia without superimposed infection improves or regresses with dose reduction or withdrawal of the offending agent [<a href="#rid33">33</a>]. In patients with paronychia induced by EGFR inhibitors, which is in most cases mild, some experts suggest treatment with topical antibiotics and potent topical corticosteroids while continuing EGFR inhibitors, with a temporary discontinuation of the offending drug limited to the most severe cases [<a href="#rid34">34</a>]. Other treatments that have been reported as beneficial in small studies include the gutter method (as used for ingrown nails) [<a href="#rid35">35</a>], red light-emitting diode [<a href="#rid36">36</a>], and a combination of topical beta blockers and topical antibiotics [<a href="#rid37">37</a>]. Topical <a class="drug drug_general" data-topicid="9997" href="/z/d/drug information/9997.html" rel="external">timolol</a> may also be beneficial for patients with periungual pyogenic granuloma complicating drug-induced paronychia [<a href="#rid38">38,39</a>]. (See  <a class="medical medical_review" href="/z/d/html/13736.html" rel="external">"Pyogenic granuloma (lobular capillary hemangioma)"</a>.)</p><p>Preemptive therapy with oral <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a>, topical corticosteroids, and moisturizers reduces the incidence of skin toxicities (including paronychia) associated with EGFR inhibitors [<a href="#rid40">40</a>]. (See  <a class="medical medical_review" href="/z/d/html/15764.html" rel="external">"Acneiform eruption secondary to epidermal growth factor receptor (EGFR) and MEK inhibitors", section on 'Preemptive therapy'</a>.)</p><p>Patients with clinical or laboratory evidence of secondary infection are treated with topical antiseptics and topical or systemic antibiotics as discussed previously. (See <a class="local">'Paronychia without abscess'</a> above and <a class="local">'Paronychia with abscess'</a> above.)</p><p class="headingAnchor" id="H612790762"><span class="h1">CHRONIC PARONYCHIA</span><span class="headingEndMark"> — </span>Chronic paronychia is an inflammatory dermatosis involving the nail folds that has been present for more than six weeks [<a href="#rid41">41</a>]. It commonly occurs in individuals persistently exposed to environmental irritants and allergens (eg, wet work, foods, chemicals), such as food handlers, farmers, health care professionals, and domestic workers. Chronic paronychia may also be associated with inflammatory skin diseases, such as atopic dermatitis and psoriasis.</p><p class="headingAnchor" id="H871196648"><span class="h2">Pathogenesis</span><span class="headingEndMark"> — </span>Chronic paronychia is considered to be an inflammatory response to repeated exposure to irritants or allergen [<a href="#rid41">41</a>]. The colonization by fungi and bacteria is thought to be a secondary occurrence rather than the initiating event. Although <em>Candida</em> spp is isolated from the proximal nail fold in 40 to 95 percent of patients with chronic paronychia, candidal infection may contribute to the persistence of the disease but should not be considered an etiologic factor, as eradication of the yeast does not cure the condition [<a href="#rid1">1,42</a>].</p><p class="headingAnchor" id="H489226887"><span class="h2">Clinical presentation</span><span class="headingEndMark"> — </span>Chronic paronychia presents initially with edema and mild erythema of the proximal and lateral nail folds with loss of the cuticle  (<a class="graphic graphic_picture graphicRef53529" href="/z/d/graphic/53529.html" rel="external">picture 11A</a>). Over time, the nail folds become hypertrophic, with marked retraction of the proximal nail fold  (<a class="graphic graphic_picture graphicRef63272" href="/z/d/graphic/63272.html" rel="external">picture 11B</a>). These changes result in continued exposure of the periungual tissues and the matrix to irritants.</p><p>Dystrophic changes of the nail plate, such as ridging and Beau lines, are often present, due to disturbed nail growth; discolorations of the nail plate due to secondary bacterial or fungal infections are also common  (<a class="graphic graphic_picture graphicRef53529" href="/z/d/graphic/53529.html" rel="external">picture 11A</a>). Episodes of acute paronychia that exacerbate the swelling and erythema may occur.</p><p class="headingAnchor" id="H1278599047"><span class="h2">Diagnosis</span><span class="headingEndMark"> — </span>The diagnosis of chronic paronychia is usually clinical, based upon the characteristic clinical findings of hypertrophy and retraction of the proximal nail fold, loss of the cuticle, and nail dystrophy  (<a class="graphic graphic_picture graphicRef53529 graphicRef63272" href="/z/d/graphic/53529.html" rel="external">picture 11A-B</a>). A history of repeated exposure to wet work, irritant chemicals, or allergens further supports the clinical diagnosis. Patch testing may be indicated in patients with suspected allergic contact dermatitis. (See  <a class="medical medical_review" href="/z/d/html/16691.html" rel="external">"Patch testing"</a>.)</p><p>A skin biopsy is generally not necessary for the diagnosis of chronic paronychia. However, in patients presenting with atypical clinical features (eg, ulceration, excessive inflammation or desquamation) and in patients with recalcitrant disease, a skin biopsy for histopathologic examination should be performed to rule out malignancy or other conditions mimicking chronic paronychia. </p><p class="headingAnchor" id="H1053813367"><span class="h2">Differential diagnosis</span><span class="headingEndMark"> — </span>Squamous cell carcinoma (SSC) and SSC in situ (Bowen disease) arising on the nail folds may mimic chronic paronychia [<a href="#rid43">43</a>]. The presentation is often that of a persistent eczematous eruption involving the periungual skin  (<a class="graphic graphic_picture graphicRef85608" href="/z/d/graphic/85608.html" rel="external">picture 12</a>) that does not improve with standard therapies [<a href="#rid44">44,45</a>]. Subungual hyperkeratosis may be an associated feature  (<a class="graphic graphic_picture graphicRef85609" href="/z/d/graphic/85609.html" rel="external">picture 13</a>). A skin biopsy can confirm the diagnosis. (See  <a class="medical medical_review" href="/z/d/html/13682.html" rel="external">"Overview of nail disorders", section on 'Malignant tumors'</a>.)</p><p>Recalcitrant chronic paronychia can rarely be the manifestation of cutaneous metastases of internal cancers [<a href="#rid46">46,47</a>], ungual leishmaniasis [<a href="#rid48">48,49</a>], and pyodermatitis-pyostomatitis vegetans associated with inflammatory bowel disease [<a href="#rid43">43</a>]. </p><p class="headingAnchor" id="H2193941350"><span class="h2">Treatment</span></p><p class="headingAnchor" id="H888612660"><span class="h3">General measures</span><span class="headingEndMark"> — </span>Avoidance of environmental triggers is an essential component of treatment of chronic paronychia. Patients should be advised to keep their hands as dry as possible and to use gloves for all wet work. Given the possible association between chronic paronychia and eczema, patients with known contact allergies should also avoid irritant or allergen exposure.</p><p class="headingAnchor" id="H4164014397"><span class="h3">First-line therapy</span><span class="headingEndMark"> — </span>We suggest topical corticosteroids rather than topical or oral antifungals as a first-line therapy for chronic paronychia, in conjunction with the skin-protection measures described above. A high-potency topical corticosteroid (group 3  (<a class="graphic graphic_table graphicRef62402" href="/z/d/graphic/62402.html" rel="external">table 3</a>)) is applied once or twice daily for two to four weeks or until improvement is noted.</p><p>The use of topical corticosteroids rather than antifungal agents for the treatment of chronic paronychia is supported by the findings of a small, well-designed, randomized trial comparing topical corticosteroids with antifungal therapy [<a href="#rid50">50</a>]. In this study, 45 patients with chronic paronychia were randomly assigned to receive one of three treatments: oral <a class="drug drug_general" data-topicid="8586" href="/z/d/drug information/8586.html" rel="external">itraconazole</a> 200 mg, oral <a class="drug drug_general" data-topicid="9677" href="/z/d/drug information/9677.html" rel="external">terbinafine</a> 250 mg, or <a class="drug drug_general" data-topicid="9639" href="/z/d/drug information/9639.html" rel="external">methylprednisolone</a> aceponate 0.1% cream (a high-potency topical corticosteroid). Trial participants given oral medications used a placebo cream, and patients receiving methylprednisolone aceponate were given an oral placebo. Patients were treated for three weeks and then followed for six more weeks. Topical methylprednisolone therapy was associated with a significantly higher cure rate compared with systemic antifungal therapy (85 versus 49 percent of nails, respectively). Only 18 patients had Candida cultured from the proximal nail fold at the beginning of the study, and of these, Candida eradication was associated with clinical cure in only two.</p><p>The topical calcineurin inhibitor <a class="drug drug_general" data-topicid="9971" href="/z/d/drug information/9971.html" rel="external">tacrolimus</a> may be an alternative therapeutic option for patients who prefer not using topical corticosteroids. Topical tacrolimus 0.1% ointment was similar in efficacy to <a class="drug drug_general" data-topicid="9139" href="/z/d/drug information/9139.html" rel="external">betamethasone</a> 17-valerate 0.1% ointment and superior to placebo in one randomized, unblinded trial of 45 patients with chronic paronychia [<a href="#rid51">51</a>].</p><p class="headingAnchor" id="H3887047307"><span class="h3">Refractory chronic paronychia</span><span class="headingEndMark"> — </span>A surgical approach is reserved for patients with recalcitrant disease that failed to respond to medical treatments. Several techniques have been proposed [<a href="#rid52">52</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>The "en bloc excision" involves the removal of a crescent-shaped, full-thickness specimen of the proximal nail fold with a maximal width of 3 to 6 mm, with or without removal of the nail plate [<a href="#rid53">53,54</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In contrast with the en bloc excision, the "square flap technique" removes only the fibrotic tissue of the nail folds, preserving the epidermis and the underlying matrix [<a href="#rid55">55</a>]. In this technique, an incision is made on both sides of the proximal nail fold and a flap is created by making an incision parallel to the epidermis at the distal-thickened proximal nail fold. This incision runs underneath the fibrotic tissue but above the nail, which is used as a guide to avoid matrix damage. The flap is tilted backward, and the fibrotic tissue is removed with the scalpel blade. The primary closure is made with a simple interrupted suture. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The "Swiss roll" technique has been proposed for both chronic paronychia and acute paronychia with runaround abscess [<a href="#rid56">56</a>]. In this technique, the nail fold is elevated by making an incision on either side and reflected proximally over a nonadherent dressing that is rolled up like a Swiss roll and fixed to the skin with two anchoring nonabsorbable sutures. The fold is kept open for 48 hours and, if the wound is clean, the sutures are removed and the proximal nail fold falls back to its original position and heals by second intention.</p><p></p><p class="headingAnchor" id="H4060650901"><span class="h2">Prevention</span><span class="headingEndMark"> — </span>Careful local skin care is advisable for the prevention of chronic paronychia. Patients should keep their hands and feet as dry as possible and not soak them in soapy water for prolonged periods of time without adequate protection. Nails should be cut carefully, and nail trauma or injury should be avoided.</p><p class="headingAnchor" id="H170561989"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/17198.html" rel="external">"Patient education: Ingrown toenail (The Basics)"</a> and  <a class="medical medical_basics" href="/z/d/html/82907.html" rel="external">"Patient education: Paronychia (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H478700"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acute paronychia</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Definition</strong> – Acute paronychia is an acute inflammatory process that involves the proximal and lateral nail folds and that has been present for &lt;6 weeks.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Etiology and predisposing factors</strong> – Acute paronychia is most commonly caused by the inoculation of pathogens present in the skin flora (eg, <em>Staphylococcus aureus</em>, <em>Streptococcus pyogenes</em>) into the periungual tissues by minor mechanical or chemical traumas (eg, manicuring, nail biting, thumbsucking, picking at a hangnail). It may also be an adverse effect of several drugs, including epidermal growth factor receptor (EGFR) inhibitors, cytotoxic chemotherapy agents, systemic retinoids, and antiretroviral agents. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Clinical presentation</strong> – Acute paronychia is characterized by the rapid onset of painful erythema and swelling of the proximal and lateral nail folds. A superficial abscess is frequently present  (<a class="graphic graphic_picture graphicRef70107 graphicRef112832 graphicRef60833" href="/z/d/graphic/70107.html" rel="external">picture 1A-C</a>). (See <a class="local">'Clinical presentation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Diagnosis</strong> – The diagnosis is usually straightforward, based upon the clinical appearance and a history of a local minor trauma. Paronychia must be distinguished from felon, an infection of the digital pulp space  (<a class="graphic graphic_picture graphicRef55298" href="/z/d/graphic/55298.html" rel="external">picture 4</a>) characterized by severe pain and swelling limited to the soft tissue around the distal phalanx. (See <a class="local">'Diagnosis'</a> above and <a class="local">'Differential diagnosis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Treatment</strong></p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Acute paronychia without abscess</strong> – For patients with acute paronychia without abscess, we suggest initial treatment with warm water or antiseptic soaks (eg, <a class="drug drug_general" data-topicid="9244" href="/z/d/drug information/9244.html" rel="external">chlorhexidine</a>, povidone-iodine) plus topical antibiotics rather than oral antibiotic therapy  (<a class="graphic graphic_algorithm graphicRef132191" href="/z/d/graphic/132191.html" rel="external">algorithm 1</a>) (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). A topical antistaphylococcal antibiotic (eg, triple antibiotic ointment or <a class="drug drug_general" data-topicid="9668" href="/z/d/drug information/9668.html" rel="external">mupirocin</a>) should be applied after each warm soak.</p><p></p><p class="bulletIndent3">Empiric oral antibiotic therapy with an antistaphylococcal agent (eg, <a class="drug drug_general" data-topicid="9349" href="/z/d/drug information/9349.html" rel="external">dicloxacillin</a> or <a class="drug drug_general" data-topicid="9231" href="/z/d/drug information/9231.html" rel="external">cephalexin</a>) is reserved for more severe cases that do not respond to topical treatment. In patients with risk factors for methicillin-resistant<em> Staphylococcus aureus</em> (MRSA) colonization  (<a class="graphic graphic_table graphicRef53504" href="/z/d/graphic/53504.html" rel="external">table 1</a>), empiric coverage for MRSA (eg, <a class="drug drug_general" data-topicid="9785" href="/z/d/drug information/9785.html" rel="external">trimethoprim-sulfamethoxazole</a>, <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">clindamycin</a>, or <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a>) may be warranted. For patients with a digit that has been exposed to oral flora (nail biting, finger sucking), antibiotic coverage should include<em> S. aureus</em>, <em>Eikenella corrodens</em>, <em>Haemophilus influenzae</em>, and beta-lactamase-producing oral anaerobic bacteria  (<a class="graphic graphic_table graphicRef80408" href="/z/d/graphic/80408.html" rel="external">table 2</a>). (See <a class="local">'Paronychia without abscess'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Acute paronychia with abscess</strong> – Acute paronychia with abscess is treated with incision and drainage followed by frequent warm soaks to help to maintain the patency of the incision and assist wound drainage. Drainage alone is sufficient for most cases of paronychia with abscess. In severe cases or in immunosuppressed patients, we suggest an adjunctive empiric oral antibiotic  (<a class="graphic graphic_algorithm graphicRef132191" href="/z/d/graphic/132191.html" rel="external">algorithm 1</a>) (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). The choice of empiric antibiotic is the same as for paronychia without abscess. When available, culture and susceptibility results should be used to tailor antibiotic therapy. (See <a class="local">'Paronychia with abscess'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chronic paronychia</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Pathogenesis</strong> – Chronic paronychia is a chronic inflammatory dermatosis involving the nail folds. It is caused by repeated exposure to irritants or allergen, with secondary colonization by fungi and bacteria. (See <a class="local">'Chronic paronychia'</a> above and <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Clinical presentation</strong> – Common clinical features of chronic paronychia include periungual erythema and swelling, loss of the cuticle, and nail dystrophy. The cause of chronic paronychia may be multifactorial. (See <a class="local">'Clinical presentation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment</strong> – Patients with chronic paronychia should be advised to keep their hands as dry as possible and to use gloves for all wet work. In addition to these general measures, we suggest topical corticosteroids rather than topical or oral antifungals as a first-line therapy (<a class="grade" href="https:///uptodate/show/grade_5" rel="external">Grade 2B</a>). A surgical approach is reserved for patients with recalcitrant disease that failed to respond to medical treatments. (See <a class="local">'First-line therapy'</a> above and <a class="local">'Refractory chronic paronychia'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Shafritz AB, Coppage JM. Acute and chronic paronychia of the hand. J Am Acad Orthop Surg 2014; 22:165.</a></li><li><a class="nounderline abstract_t">Shroff PS, Parikh DA, Fernandez RJ, Wagle UD. Clinical and mycological spectrum of cutaneous candidiasis in Bombay. J Postgrad Med 1990; 36:83.</a></li><li><a class="nounderline abstract_t">Alam M, Scher RK. Indinavir-related recurrent paronychia and ingrown toenails. Cutis 1999; 64:277.</a></li><li><a class="nounderline abstract_t">Tosti A, Piraccini BM, D'Antuono A, et al. Paronychia associated with antiretroviral therapy. Br J Dermatol 1999; 140:1165.</a></li><li><a class="nounderline abstract_t">Robert C, Sibaud V, Mateus C, et al. Nail toxicities induced by systemic anticancer treatments. Lancet Oncol 2015; 16:e181.</a></li><li><a class="nounderline abstract_t">Garden BC, Wu S, Lacouture ME. The risk of nail changes with epidermal growth factor receptor inhibitors: a systematic review of the literature and meta-analysis. J Am Acad Dermatol 2012; 67:400.</a></li><li><a class="nounderline abstract_t">Rigopoulos D, Larios G, Gregoriou S, Alevizos A. Acute and chronic paronychia. Am Fam Physician 2008; 77:339.</a></li><li><a class="nounderline abstract_t">Brook I. Paronychia: a mixed infection. Microbiology and management. J Hand Surg Br 1993; 18:358.</a></li><li><a class="nounderline abstract_t">Brook I. Bacteriologic study of paronychia in children. Am J Surg 1981; 141:703.</a></li><li><a class="nounderline abstract_t">Figueiras Dde A, Ramos TB, Marinho AK, et al. Paronychia and granulation tissue formation during treatment with isotretinoin. An Bras Dermatol 2016; 91:223.</a></li><li><a class="nounderline abstract_t">Blumental G. Paronychia and pyogenic granuloma-like lesions with isotretinoin. J Am Acad Dermatol 1984; 10:677.</a></li><li><a class="nounderline abstract_t">Durdu M, Ruocco V. Clinical and cytologic features of antibiotic-resistant acute paronychia. J Am Acad Dermatol 2014; 70:120.</a></li><li><a class="nounderline abstract_t">Sibel S, Macher A, Goosby E. Paronychia in patients receiving antiretroviral therapy for human immunodeficiency virus infection. J Am Podiatr Med Assoc 2000; 90:98.</a></li><li><a class="nounderline abstract_t">Colson AE, Sax PE, Keller MJ, et al. Paronychia in association with indinavir treatment. Clin Infect Dis 2001; 32:140.</a></li><li><a class="nounderline abstract_t">García-Silva J, Almagro M, Peña-Penabad C, Fonseca E. Indinavir-induced retinoid-like effects: incidence, clinical features and management. Drug Saf 2002; 25:993.</a></li><li><a class="nounderline abstract_t">Lomax A, Thornton J, Singh D. Toenail paronychia. Foot Ankle Surg 2016; 22:219.</a></li><li><a class="nounderline abstract_t">Lipner SR, Scher RK. Congenital Malalignment of the Great Toenails With Acute Paronychia. Pediatr Dermatol 2016; 33:e288.</a></li><li><a class="nounderline abstract_t">Patel DB, Emmanuel NB, Stevanovic MV, et al. Hand infections: anatomy, types and spread of infection, imaging findings, and treatment options. Radiographics 2014; 34:1968.</a></li><li><a class="nounderline abstract_t">Clark DC. Common acute hand infections. Am Fam Physician 2003; 68:2167.</a></li><li><a class="nounderline abstract_t">Turkmen A, Warner RM, Page RE. Digital pressure test for paronychia. Br J Plast Surg 2004; 57:93.</a></li><li><a class="nounderline abstract_t">Langley A, Asai Y. Pustules of the fingers: acrodermatitis continua. CMAJ 2016; 188:1105.</a></li><li><a class="nounderline abstract_t">Tosti A, Piraccini BM, Lorenzi S. Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases. J Am Acad Dermatol 2000; 42:217.</a></li><li><a class="nounderline abstract_t">Hengge UR, Bardeli V. Images in clinical medicine. Green nails. N Engl J Med 2009; 360:1125.</a></li><li><a class="nounderline abstract_t">de Berker DA, Richert B, Duhard E, et al. Retronychia: proximal ingrowing of the nail plate. J Am Acad Dermatol 2008; 58:978.</a></li><li><a class="nounderline abstract_t">Lee HE, Wong WR, Lee MC, Hong HS. Acute paronychia heralding the exacerbation of pemphigus vulgaris. Int J Clin Pract 2004; 58:1174.</a></li><li><a class="nounderline abstract_t">Serratos BD, Rashid RM. Nail disease in pemphigus vulgaris. Dermatol Online J 2009; 15:2.</a></li><li><a class="nounderline abstract_t">Tosti A, André M, Murrell DF. Nail involvement in autoimmune bullous disorders. Dermatol Clin 2011; 29:511.</a></li><li><a class="nounderline abstract_t">Shaw J, Body R. Best evidence topic report. Incision and drainage preferable to oral antibiotics in acute paronychial nail infection? Emerg Med J 2005; 22:813.</a></li><li><a class="nounderline abstract_t">Wollina U. Acute paronychia: comparative treatment with topical antibiotic alone or in combination with corticosteroid. J Eur Acad Dermatol Venereol 2001; 15:82.</a></li><li><a class="nounderline abstract_t">Tosti R, Ilyas AM. Empiric antibiotics for acute infections of the hand. J Hand Surg Am 2010; 35:125.</a></li><li><a class="nounderline abstract_t">Pierrart J, Delgrande D, Mamane W, et al. Acute felon and paronychia: Antibiotics not necessary after surgical treatment. Prospective study of 46 patients. Hand Surg Rehabil 2016; 35:40.</a></li><li><a class="nounderline abstract_t">Ogunlusi JD, Oginni LM, Ogunlusi OO. DAREJD simple technique of draining acute paronychia. Tech Hand Up Extrem Surg 2005; 9:120.</a></li><li><a class="nounderline abstract_t">Piraccini BM, Iorizzo M. Drug reactions affecting the nail unit: diagnosis and management. Dermatol Clin 2007; 25:215.</a></li><li><a class="nounderline abstract_t">Melosky B, Leighl NB, Rothenstein J, et al. Management of egfr tki-induced dermatologic adverse events. Curr Oncol 2015; 22:123.</a></li><li><a class="nounderline abstract_t">Agematsu A, Kamata M, Namiki K, et al. Usefulness of Noninvasive Management With the Gutter Method for Epidermal Growth Factor Receptor Inhibitor-Induced Paronychia, Pyogenic Granuloma-Like Lesion, and Ingrown Nail. JAMA Dermatol 2022; 158:583.</a></li><li><a class="nounderline abstract_t">Jornsamer C, Theerawattanawit C, Wichayachakorn C, et al. Red light emitting diode as an adjuvant treatment for epidermal growth factor receptor inhibitors-induced paronychia. J Dermatolog Treat 2022; 33:1990.</a></li><li><a class="nounderline abstract_t">Liu HL, Chuang CH, Chen CL, et al. Combination of available topical beta-blockers and antibiotic ointment for epidermal growth factor receptor tyrosine kinase inhibitor-induced paronychia and pseudopyogenic granulomas in Taiwan. J Oncol Pharm Pract 2023; 29:1374.</a></li><li><a class="nounderline abstract_t">Sibaud V, Casassa E, D'Andrea M. Are topical beta-blockers really effective "in real life" for targeted therapy-induced paronychia. Support Care Cancer 2019; 27:2341.</a></li><li><a class="nounderline abstract_t">Wollina U. Systemic Drug-induced Chronic Paronychia and Periungual Pyogenic Granuloma. Indian Dermatol Online J 2018; 9:293.</a></li><li><a class="nounderline abstract_t">Lacouture ME, Mitchell EP, Piperdi B, et al. Skin toxicity evaluation protocol with panitumumab (STEPP), a phase II, open-label, randomized trial evaluating the impact of a pre-Emptive Skin treatment regimen on skin toxicities and quality of life in patients with metastatic colorectal cancer. J Clin Oncol 2010; 28:1351.</a></li><li><a class="nounderline abstract_t">Rocha BP, Verardino G, Leverone A, et al. Histopathological analysis of chronic paronychia. Int J Dermatol 2023; 62:514.</a></li><li><a class="nounderline abstract_t">Rockwell PG. Acute and chronic paronychia. Am Fam Physician 2001; 63:1113.</a></li><li><a class="nounderline abstract_t">Jack C, El Helou T. Non-healing ulcerative paronychia. Lancet 2017; 389:1740.</a></li><li><a class="nounderline abstract_t">Giacomel J, Lallas A, Zalaudek I, Argenziano G. Periungual Bowen disease mimicking chronic paronychia and diagnosed by dermoscopy. J Am Acad Dermatol 2014; 71:e65.</a></li><li><a class="nounderline abstract_t">Lobato-Berezo A, Fernandez-Valencia-Kettunen CK, Burgos-Lazaro F, et al. Ungual squamous cell carcinoma mimicking a chronic paronychia: clinical, pathological and radiological correlation. Dermatol Online J 2015; 21.</a></li><li><a class="nounderline abstract_t">Lee CC, Wu YH. Paronychia-like digital metastases of osteosarcoma. Int J Dermatol 2017; 56:104.</a></li><li><a class="nounderline abstract_t">Ko JH, Young A, Wang KH. Paronychia-like digital cutaneous metastasis. Br J Dermatol 2014; 171:663.</a></li><li><a class="nounderline abstract_t">Chiheb S, El Machbouh L, Marnissi F. Paronychia-like cutaneous leishmaniasis. Dermatol Online J 2015; 21.</a></li><li><a class="nounderline abstract_t">Chaabane H, Turki H. Images in clinical medicine. Cutaneous leishmaniasis with a paronychia-like lesion. N Engl J Med 2014; 371:1736.</a></li><li><a class="nounderline abstract_t">Tosti A, Piraccini BM, Ghetti E, Colombo MD. Topical steroids versus systemic antifungals in the treatment of chronic paronychia: an open, randomized double-blind and double dummy study. J Am Acad Dermatol 2002; 47:73.</a></li><li><a class="nounderline abstract_t">Rigopoulos D, Gregoriou S, Belyayeva E, et al. Efficacy and safety of tacrolimus ointment 0.1% vs. betamethasone 17-valerate 0.1% in the treatment of chronic paronychia: an unblinded randomized study. Br J Dermatol 2009; 160:858.</a></li><li><a class="nounderline abstract_t">Relhan V, Goel K, Bansal S, Garg VK. Management of chronic paronychia. Indian J Dermatol 2014; 59:15.</a></li><li><a class="nounderline abstract_t">Grover C, Bansal S, Nanda S, et al. En bloc excision of proximal nail fold for treatment of chronic paronychia. Dermatol Surg 2006; 32:393.</a></li><li><a class="nounderline abstract_t">Baran R, Bureau H. Surgical treatment of recalcitrant chronic paronychias of the fingers. J Dermatol Surg Oncol 1981; 7:106.</a></li><li><a class="nounderline abstract_t">Ferreira Vieira d'Almeida L, Papaiordanou F, Araújo Machado E, et al. Chronic paronychia treatment: Square flap technique. J Am Acad Dermatol 2016; 75:398.</a></li><li><a class="nounderline abstract_t">Pabari A, Iyer S, Khoo CT. Swiss roll technique for treatment of paronychia. Tech Hand Up Extrem Surg 2011; 15:75.</a></li></ol></div><div id="topicVersionRevision">Topic 5574 Version 29.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24603826" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Acute and chronic paronychia of the hand.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2097373" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Clinical and mycological spectrum of cutaneous candidiasis in Bombay.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10544885" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Indinavir-related recurrent paronychia and ingrown toenails.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10354091" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Paronychia associated with antiretroviral therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25846098" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Nail toxicities induced by systemic anticancer treatments.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22088429" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : The risk of nail changes with epidermal growth factor receptor inhibitors: a systematic review of the literature and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18297959" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Acute and chronic paronychia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8345268" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Paronychia: a mixed infection. Microbiology and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6972709" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Bacteriologic study of paronychia in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27192525" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Paronychia and granulation tissue formation during treatment with isotretinoin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6585376" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Paronychia and pyogenic granuloma-like lesions with isotretinoin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24355264" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Clinical and cytologic features of antibiotic-resistant acute paronychia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10697975" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Paronychia in patients receiving antiretroviral therapy for human immunodeficiency virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11118393" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Paronychia in association with indinavir treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12408731" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Indinavir-induced retinoid-like effects: incidence, clinical features and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27810017" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Toenail paronychia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27396767" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Congenital Malalignment of the Great Toenails With Acute Paronychia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25384296" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Hand infections: anatomy, types and spread of infection, imaging findings, and treatment options.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14677662" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Common acute hand infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14672686" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Digital pressure test for paronychia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27026671" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Pustules of the fingers: acrodermatitis continua.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10642676" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19279344" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Images in clinical medicine. Green nails.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18375016" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Retronychia: proximal ingrowing of the nail plate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15646419" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Acute paronychia heralding the exacerbation of pemphigus vulgaris.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19903430" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Nail disease in pemphigus vulgaris.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21605819" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Nail involvement in autoimmune bullous disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16244344" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Best evidence topic report. Incision and drainage preferable to oral antibiotics in acute paronychial nail infection?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11451337" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Acute paronychia: comparative treatment with topical antibiotic alone or in combination with corticosteroid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20117314" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Empiric antibiotics for acute infections of the hand.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27117023" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Acute felon and paronychia: Antibiotics not necessary after surgical treatment. Prospective study of 46 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16201254" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : DAREJD simple technique of draining acute paronychia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17430758" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Drug reactions affecting the nail unit: diagnosis and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25908911" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Management of egfr tki-induced dermatologic adverse events.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35416917" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Usefulness of Noninvasive Management With the Gutter Method for Epidermal Growth Factor Receptor Inhibitor-Induced Paronychia, Pyogenic Granuloma-Like Lesion, and Ingrown Nail.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33961534" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Red light emitting diode as an adjuvant treatment for epidermal growth factor receptor inhibitors-induced paronychia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36112905" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Combination of available topical beta-blockers and antibiotic ointment for epidermal growth factor receptor tyrosine kinase inhibitor-induced paronychia and pseudopyogenic granulomas in Taiwan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30847700" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Are topical beta-blockers really effective "in real life" for targeted therapy-induced paronychia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30258794" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Systemic Drug-induced Chronic Paronychia and Periungual Pyogenic Granuloma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20142600" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Skin toxicity evaluation protocol with panitumumab (STEPP), a phase II, open-label, randomized trial evaluating the impact of a pre-Emptive Skin treatment regimen on skin toxicities and quality of life in patients with metastatic colorectal cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36631425" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Histopathological analysis of chronic paronychia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11277548" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Acute and chronic paronychia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28017401" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Non-healing ulcerative paronychia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25128126" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Periungual Bowen disease mimicking chronic paronychia and diagnosed by dermoscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26632936" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Ungual squamous cell carcinoma mimicking a chronic paronychia: clinical, pathological and radiological correlation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27495265" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Paronychia-like digital metastases of osteosarcoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24690016" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Paronychia-like digital cutaneous metastasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26632940" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Paronychia-like cutaneous leishmaniasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25354107" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Images in clinical medicine. Cutaneous leishmaniasis with a paronychia-like lesion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12077585" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Topical steroids versus systemic antifungals in the treatment of chronic paronychia: an open, randomized double-blind and double dummy study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19120329" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Efficacy and safety of tacrolimus ointment 0.1% vs. betamethasone 17-valerate 0.1% in the treatment of chronic paronychia: an unblinded randomized study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24470654" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Management of chronic paronychia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16640685" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : En bloc excision of proximal nail fold for treatment of chronic paronychia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7217504" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Surgical treatment of recalcitrant chronic paronychias of the fingers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26946988" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Chronic paronychia treatment: Square flap technique.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21606775" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Swiss roll technique for treatment of paronychia.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
